- Home
- OPTT vs CGTX Comparison
OPTT vs CGTX Comparison
Compare OPTT & CGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | OPTT | CGTX |
|---|---|---|
| Founded | 1984 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 81.9M | 94.5M |
| IPO Year | 2006 | 2021 |
Fundamental Metrics
Financial Performance| Metric | OPTT | CGTX |
|---|---|---|
| Price | $0.39 | $1.15 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | $1.50 | ★ $3.33 |
| AVG Volume (30 Days) | ★ 3.2M | 1.5M |
| Earning Date | 03-17-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 63.83 | 62.79 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $5,861,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $221.57 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 6.08 | N/A |
| 52 Week Low | $0.29 | $0.22 |
| 52 Week High | $0.90 | $3.83 |
Technical Indicators
Market Signals| Indicator | OPTT | CGTX |
|---|---|---|
| Relative Strength Index (RSI) | 51.66 | 60.40 |
| Support Level | $0.30 | $1.01 |
| Resistance Level | $0.39 | $1.19 |
| Average True Range (ATR) | 0.02 | 0.09 |
| MACD | 0.00 | 0.04 |
| Stochastic Oscillator | 71.61 | 92.63 |
Price Performance
Historical ComparisonAbout OPTT Ocean Power Technologies Inc.
Ocean Power Technologies Inc provides intelligent maritime solutions and services that enable safer, cleaner, and more productive ocean operations for the defense and security, oil and gas, science and research, and offshore wind markets. It provides ocean data collection and reporting, marine power, offshore communications, and Maritime Domain Awareness System (MDAS) products, integrated solutions, and consulting services. The company offers its products and services to a wide range of customers, including those in government and offshore energy, oil and gas, construction, wind power, and other industries. The company has operations in North and South America, Europe, Asia and Australia.
About CGTX Cognition Therapeutics Inc.
Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.